Research Topics
| P AstoulSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Pleural mesotheliomaP Astoul
Department of Pulmonology, Hopital de la Conception, Marseille, France
Curr Opin Pulm Med 5:259-68. 1999..To reach this target, all patients must be enrolled in protocols. The usual pessimism for the management of patients with malignant pleural mesothelioma is over...- Diagnostic and therapeutic thoracoscopy: techniques and indications in pulmonary medicineC Boutin
Service de Pneumologie, Hopital de la Conception, Marseille, France
Tuber Lung Dis 74:225-39. 1993..The other therapeutic procedures described here are sympathectomy for palmar hyperhidrosis, pulmonary biopsy using an endo-GIA stapler and pericardial biopsy... - Feasibility of short term drainage for diagnostic thoracoscopyD P Breen
Faculty of Medicine, Universite de la Mediterranee, Assistance Publique Hopitaux de Marseille, Department of Pulmonary Diseases, Division of Thoracic Oncology, Hopital Sainte Marguerite, Marseille, France
Monaldi Arch Chest Dis 71:54-8. 2009..Our aim was to retrospectively study all cases of diagnostic thoracoscopy and to ascertain the time of chest drain removal, length of hospital stay and associated complications... - [Diagnostic and therapeutic thoracoscopy]P Astoul
Service de Pneumologie, Hopital de la Conception, Marseille
Rev Prat 47:1308-14. 1997..In diffuse pulmonary diseases, thoracoscopy also allows lung biopsy. Some therapeutic measures are mainly feasible by this route. Pleurodesis is performed in case of recurrent pleural effusion of for pneumothorax... - Diagnostic thoracoscopyC Boutin
Department of Pulmonology, Hopital de la Conception, Marseille, France
Clin Chest Med 19:295-309. 1998..This article focuses on the technique, indications, and results of medical thoracoscopy... - [Role of DNA microarrays in the diagnosis of pleural exudates: a feasibility study]L Greillier
Faculte de Medecine, Universite de la Mediterranee, Assistance Publique Hopitaux de Marseille, Service d Oncologie Thoracique, Pôle thorax, Hopital Sainte Marguerite, Marseille, France
Rev Mal Respir 24:859-67. 2007..The aim of this study was to determine the feasibility and the diagnostic contribution of genomic analysis of cells contained in pleural fluid, using DNA microarray techniques... 
Malignant pleural mesothelioma: from the bench to the bedsideP Astoul
Department of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hopital Nord, Marseille, France
Respiration 83:481-93. 2012..Thus, this review is an overview of the recent advances in the biology of MPM and their potential therapeutic applications in the field of MPM diagnosis and treatment...- [Pleural mesothelioma: impact of the staging for the therapeutic strategy]L Greillier
Departement des Maladies Respiratoires, Unité d Oncologie Thoracique, Hopital Sainte Marguerite, Marseille, France
Rev Mal Respir 24:6S146-56. 2007..However, the most important point is the multidisciplinary concertation induced by the management of this disease which represents a "model" in thoracic oncology... - [Validation of the French version of the Princess Margaret Hospital Patient Satisfaction with their Doctor Questionnaire]F Barlesi
Service d Oncologie Thoracique, Fédération des Maladies Respiratoires, Hopital Sainte Marguerite, Faculté de Médecine Université de la Méditerranée, Marseille, France
Rev Mal Respir 23:227-36. 2006..Outpatients' satisfaction with their doctor is a major component of total patient satisfaction. However, a validated instrument for assessing this has not previously been available in French... - [Listening to the patient]P Astoul
, , , Marseille, France
Rev Mal Respir 23:10S27-10S30. 2006 - [Clinical types of thoracic cancer. Pleural mesothelioma]P Astoul
Departement des Maladies Respiratoires, Unité d Oncologie Thoracique, Hopital Sainte Marguerite, Marseille, France
Rev Mal Respir 23:16S177-16S187. 2006.... - [Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer]C Tummino
Faculte de Medecine, Université de la Méditerranée Assistance Publique Hôpitaux de Marseille, Service d Oncologie Thoracique, Hopital Sainte Marguerite, Marseille, France
Rev Mal Respir 24:635-8. 2007..However, cutaneous toxicity has been described, principally as a rash. Cutaneous toxicity of all grades has been observed in up to 14%, and grade 3 or 4 toxicity in 0.8-1.3% of cases... - [Mucoepidermoid bronchial tumor with an unusual radiologic presentation]C Pinet
Service de Pneumologie, Hopital de la Conception, Marseille
Rev Mal Respir 16:379-81. 1999..The prognosis is much better for tumors of low-grade malignancy and current treatment is surgical in the absence of recurrence after isolated endoscopic treatment... - [Chronic atrophic polychondritis. Clinical polymorphism and severity of respiratory lesions]P Astoul
Service de Pneumologie, Hopital de la Conception, Marseille
Rev Mal Respir 10:251-4. 1993..Either general or local treatment is virtually non-existent and the prognosis of these extensive respiratory forms of the disease is very poor... - [Acute respiratory distress syndrome following inhalation of barium sulfate]Y Gernez
, , , , , Marseille, France
Rev Mal Respir 22:477-80. 2005..Thus, a close watch over respiratory symptoms has to be kept after BS administration, especially in debilitated and elderly patients... - [Phase III randomised trial of adjuvant chemotherapy with cisplatin plus docetaxel versus cisplatin plus gemcitabine in resected non-small cell bronchial carcinoma with quality of life as the primary objective]F Barlesi
Faculté de Médecine Université de la Méditerranée, Assistance Publique Hopitaux de Marseille, Service d Oncologie Thoracique, Fédération des Maladies Respiratoires, France
Rev Mal Respir 23:489-96. 2006..Adjuvant chemotherapy improves survival of completely resected non-small cell lung cancer (NSCLC). However the regimen of choice is not yet defined... - [Malignant mesothelioma of the pleura: place of surgery]R Giudicelli
, , Marseille
Rev Mal Respir 23:10S106-10S109. 2006 
The French National Mesothelioma Surveillance ProgramM Goldberg
Département Santé Travail, Institut de Veille Sanitaire, 12, rue du Val d Osne, 94410 Saint Maurice, France
Occup Environ Med 63:390-5. 2006....- [Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]E Touboul
, Paris, France
Cancer Radiother 5:452-63. 2001.... - [Bronchoscopy in the diagnosis of lung cancer: an evaluation of current practice]F Barlesi
Service d Oncologie Thoracique, Fédération des Maladies Respiratoires, Faculté de Médecine Université de la Méditerranée, Assistance Publique Hopitaux de Marseille, Marseille France
Rev Mal Respir 23:4S17-4S26. 2006..Bronchoscopy is frequently practised by respiratory physicians, particularly when there is a suspicion of lung cancer. However, few guidelines are available and practice varies widely... - [Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]E Bardet
Standards, Options, Recommandations, 101, rue de Tolbiac, 75654 Paris Cedex 13
Bull Cancer 88:369-87. 2001..Surgery is justified in stage N2 disease as good local control can be achieved. T4-N0 disease should be treated surgically with curative intent... - Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)A Depierre
, , France
Br J Cancer 89:S35-49. 2003 - [Prognostic indicators in stage I non-small cell lung cancer]F Barlesi
Departement des Maladies Respiratoires, Universite de la Mediterrannee, Hopitaux de Marseille, France
Rev Mal Respir 21:93-103. 2004..Better knowledge of prognostic factors could perhaps define which patient populations should be targeted with such treatments... - [2000 classification of idiopathic interstitial lung diseases]S Boniface
UPRES EA 3287, Departement des Maladies Respiratoires, Universite de la Mediterranee, Hopital Sainte Marguerite, Marseille, France
Rev Med Interne 25:891-905. 2004..A better characterization of anatomoclinical entities should lead to a better pronostic evaluation, more informative comparisons of published studies, and therefore to rational therapeutic approach... - CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapyF Barlesi
Department of Thoracic Oncology, Faculty of Medicine, Assistance Publique Hopitaux de Marseille, Fédération des Maladies Respiratoires, Hopital Sainte Marguerite, 270, Bd de Sainte Marguerite, 13274 Marseille Cedex 09, France
Br J Cancer 92:13-4. 2005..In case of a CYFRA 21-1 level higher than 3.5 ng ml(-1), treatment with gefitinib needs further evaluation giving its relative poor effect on survival... - Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lungF Barlesi
Faculty of Medicine Assistance Publique Hôpitaux de Marseille, Department of Thoracic Oncology, Fédération des Maladies Respiratoires, Hopital Sainte Marguerite, Marseille, France
Br J Cancer 93:450-2. 2005..30-0.85; P = 0.01) and higher grade of differentiation (HR = 0.40, 95% CI 0.24-0.68; P = 0.001). In conclusion, positive TTF1 staining strongly and independently correlates with survival of patients with primary ADC of the lung... - [Cutaneous metastasis of pleural mesothelioma: two cases]C Gaudy-Marqueste
, , Marseille
Ann Dermatol Venereol 130:455-9. 2003.... - [Reducing the risks associated with bronchoscopy: a call for a standardisation of practice]P Astoul
Rev Mal Respir 20:319-22. 2003 - Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomised studyJ M Tschopp
Centre valaisan de pneumologie, Montana, Switzerland
Eur Respir J 20:1003-9. 2002.... - [Malignant pleural mesothelioma: role of excisional surgery]R Giudicelli
Chirurgie Thoracique, CHU, Marseille
Rev Mal Respir 23:11S51-5. 2006 - [Which criteria for the anatomopathologic diagnosis of malignant pleural mesothelioma?]F Galateau-Salle
Groupe Mesopath, CHU Caen
Rev Mal Respir 23:11S37-44. 2006 - [Which diagnostic criteria for malignant pleural mesothelioma (MPM)?]P Astoul
CHU Marseille, France
Rev Mal Respir 23:11S29-35. 2006 - [How to assess asbestos exposure and identify a population at risk?]J C Pairon
Service de pneumologie et pathologie professionnelle, CHI Creteil, et INSERM E03 37, Faculte de Medecine, Creteil, France
Rev Mal Respir 23:11S9-27. 2006 - Management of spontaneous pneumothorax: state of the artJ M Tschopp
Valais Pneumology Centre, Crans Montana, Switzerland
Eur Respir J 28:637-50. 2006..Moreover, all of these new techniques should be better standardised to permit comparison in randomised controlled studies... - [Use of 153Sm-EDTMP to relieve pain from bone metastasis in lung cancer]H Ratsimanohatra
Service des Maladies Respiratoires, , CHU Antananarivo, Madagascar
Rev Mal Respir 22:317-20. 2005.... - [Hypersensitivity to carboplatin. An effect of generic drugs?]Y Gernez
Faculte de Medecine, Universite de la Mediterranee, Service de pneumologie allergologie Hôpital Sainte Marguerite Marseille, France
Rev Mal Respir 23:269-72. 2006..Carboplatin is a chemotherapeutic agent used frequently in thoracic medicine on account of its relatively good tolerance. Nevertheless hypersensitivity reactions have been described...